We examined the upregulation of ET-1/ETBR/eNOS signaling in renoprotective effect of
vitamin D in kidney
fibrosis model in mice using unilateral
ureteral obstruction (UUO). One group was treated with
intraperitoneal injection of 0.125 mg/kg of
Calcitriol (UUO+VD).
Vascular remodeling was quantified based on lumen area and lumen/wall area ratio (LWAR) of intrarenal arteries using Sirius Red staining. ET-1, ETBR, eNOS, CD31 and
VEGF mRNA expressions were quantified using qRT-PCR. Focusing on
endothelin-1 (ET-1) signaling in endothelial cells (EC),
siRNA of ET-1 was performed in human umbilical vein endothelial cells (HUVEC) for reducing ET-1 expression. Then HUVECs were treated with and without 100 nM
Calcitriol treatment in hypoxic and normoxic conditions to elucidate ET-1/eNOS signaling. Our in vivo study revealed
vascular remodeling and renal
ischemia attenuation after
Calcitriol treatment.
Vascular remodeling was attenuated in the UUO+VD group as shown by increasing lumen areas and LWAR in intrarenal arteries. These findings were associated with significant higher CD31 and
VEGF mRNA expression compared to the UUO group.
Vitamin D treatment also increased ET-1, ETBR and eNOS
mRNA expressions. Our in vitro study demonstrated
Calcitriol induced ET-1 and eNOS
mRNA expressions upregulation in HUVEC under normoxic and hypoxic condition. Meanwhile,
siRNA for ET-1 inhibited the upregulation of eNOS
mRNA expression after
Calcitriol treatment.
Vitamin D ameliorates kidney
fibrosis through attenuating
vascular remodeling and
ischemia with upregulating ET-1/ETBR and eNOS expression.